Please wait
HEALTHCARE · Pharmaceutical Preparations · Price, fundamentals, signals, and forward-looking context in one research view.
HEALTHCARE
₦63.8B
1.1%
11.71
Current price
₦37.00
0.0% todayUpdated 37 min ago
Open
₦37.00
Previous close
₦37.00
Day range
₦37.00 – ₦37.00
Volume
313,273
11.7x P/E
Awaiting filing
1.1% yield
65/100 measured
Moderate liquidity
Recent price movement, key market context and the latest company information.
The latest saved price history for MAYBAKER, with its range and direction at a glance.
1 pages were reviewed. Open the update for the summary and original document.
May & Baker Nigeria Plc, together with its subsidiaries, manufactures, sells, and distributes human pharmaceuticals, human vaccines, and consumer products in Nigeria. It operates through Pharmaceuticals and Beverage segments. The company offers pharmaceuticals, including anti-diabetic, anti-hypersensitive, anti-infective, anti-malaria, analgesic, cough and cold, and anxiolytics; and nature care products. It also provides beverage drinks, including bottled water under the Lily Water name; and hand and surface sanitizers under the Smartans name. In addition, the company engages in contract manufacturing of pharmaceutical products; and in healthcare and industrial packaging. May & Baker Nigeria Plc was incorporated in 1944 and is headquartered in Lagos, Nigeria.
Investors usually follow MAYBAKER for its dividend profile, valuation signal, sector position, and upcoming company events. The goal here is not just to show numbers, but to explain what they mean in plain English.
Whisone is bullish because fundamentals are solid at 80/100 while turnover is thin at 0.029%. Whisone has high conviction here. The final read is being balanced by the weighted scores for fundamentals, technicals, insider flow, sentiment, event flow, and liquidity.
Whisone v2 splits the read into weighted parts so the score is not just one hidden number.
Fundamentals
Growth, margins, cash flow, and valuation.
Sentiment
Market mood from flow, events, and attention.
Latest net profit
₦5.45B
TTM (2026-08-31)
ROE
11.9%
Return on equity
ROA
6.3%
Return on assets
Debt / equity
0.18
Lower is usually safer.
P/B ratio
4.00
Useful for book value support.
Dividend yield
1.1%
Current income signal.
77/100
Direction
Range-bound
Main supports
Business quality and balance-sheet strength are supporting the outlook.
Recent price and fundamentals refreshes improve signal reliability.
What can go wrong
Volatility is elevated, so the path can stay rough even if the thesis is right.
Fair value
₦37.00
Analyst view
n/a
Forecast refresh
Updated just now
Quality score
79
Growth score
50
These are the external analyst numbers and business outlook figures already synced into the company record.
No external analyst outlook is available for this company yet.
A plain-English reading of momentum, trend, volatility, range position, and trading participation.
RSI
28.7
Momentum is weak and the stock is in oversold territory.
Recent trend
Falling
-5.1% across the latest saved price window.
Volatility
Low
Beta is 0.69. Price has historically moved more calmly than the wider market.
52-week position
58% of range
Price is sitting around the middle of its 52-week range.
Volume confirmation
0.62x average
Trading activity is broadly within its normal range.
The sector would benefit from extended Presidential Executive Order, dedicated energy tariffs, and policies encouraging local API production to attract investment and boost local manufacturing.
delayed_input_clearance
MAYBAKER may move with delayed_input_clearance. Confidence 80%.
The group cited delayed clearance of pharma inputs as a major threat to competitiveness of local manufacturers.
Sector spillover signals
high_energy_costs
MAYBAKER may also move because the HEALTHCARE sector may move with high_energy_costs. Confidence 90%.
PMG-MAN stated the pharmaceutical sector spends a large share of revenue on energy, reducing competitiveness industry-wide.
policy_stability_and_support
MAYBAKER may also move because the HEALTHCARE sector may benefit from policy_stability_and_support. Confidence 85%.
The sector would benefit from extended Presidential Executive Order, dedicated energy tariffs, and policies encouraging local API production to attract investment and boost local manufacturing.
q1_2026_gdp_growth
MAYBAKER may also move because the HEALTHCARE sector may move with q1_2026_gdp_growth. Confidence 63%.
NBS data cited in the article shows the healthcare sector grew by 1.99% in Q1 2026 (vs 1.76% in Q1 2025), indicating sector-level growth dynamics affecting listed healthcare firms.
local manufacturing / import substitution
MAYBAKER may also move because the HEALTHCARE sector may benefit from local manufacturing / import substitution. Confidence 56%.
The article notes Nigeria's pharmaceutical firms are investing in local manufacturing and import substitution to reduce dependence on foreign supply, a trend that supports domestic pharma firms' growth and access.
local_manufacturing_and_access
MAYBAKER may also move because the HEALTHCARE sector may benefit from local_manufacturing_and_access. Confidence 56%.
MeCure's emphasis on affordable, locally manufactured medicines and wider market penetration illustrates sector-level support for improved local manufacturing and access to quality medicines.
manufacturing infrastructure
MAYBAKER may also move because the HEALTHCARE sector may benefit from manufacturing infrastructure. Confidence 56%.
Completion of a pharmaceutical manufacturing facility by Neimeth increases manufacturing capacity in the healthcare sector.
local_manufacturing_and_product_innovation
MAYBAKER may also move because the HEALTHCARE sector may move with local_manufacturing_and_product_innovation. Confidence 53%.
MeCure's focus on deepening local manufacturing, product innovation, and expanded market penetration reflects sector-wide themes of local production and access to affordable medicines.
profit-taking
MAYBAKER may also move because the HEALTHCARE sector may move with profit-taking. Confidence 53%.
Profit-taking is identified in the article as a trigger for the sell-off impacting SWOOT stocks.
MAYBAKER
May & Baker Nigeria Plc
Price: ₦37.00
P/E: 11.71
Yield: 1.1%
EKOCORP
Eko Corporation Plc
Price: ₦5.80
P/E: N/A
Yield: N/A
FIDSON
Fidson Healthcare Plc
Price: ₦79.00
P/E: 18.33
Yield: 1.6%
MECURE
MeCure Industries Plc
Price: ₦56.20
P/E: 31.17
Yield: 0.6%
Industry
Pharmaceutical Preparations
Founded
1944
Employees
409
Exchange
NGX
Ticker
MAYBAKER
2026-08-18
MAY AND BAKER-NOTICE OF OUTCOME OF BOARD MEETING
2026-07-29
MAY AND BAKER- QUARTER 2 - FINANCIAL STATEMENT FOR 2026
2026-07-29
9.25
